The European leader in remote monitoring of implantable cardiac devices, Implicity, was selected during a call for tenders within the AP-HP to be used for eight hospitals: Hôpital Européen Georges-Pompidou, Pitié Salpêtrière, Henri-Mondor, Bichat-Claude Bernard,...
Paris, le 19 juillet 2021 – Bayer, acteur majeur dans le domaine de la cardiologie et Implicity, leader européen de la télésurveillance des dispositifs cardiaques implantables, annoncent la signature d’un partenariat de co-promotion de la solution d’insuffisance...
CAMBRIDGE, Mass., June 22, 2021 /PRNewswire/ — Implicity, a leader in remote patient monitoring software and cardiac data management solutions, today announced the addition of Tim Laird as Vice President of Sales–North America. Laird is an accomplished sales...
Paris, June 3, 2021 – Implicity, in collaboration with Withings, announces the official launch of its complete solution for monitoring heart failure patients. Implicity expands its line of products and services with a dedicated heart failure solution. The...
Deal allows global cardiac device manufacturer to enhance its offerings in the U.S. with Implicity’s cloud-based and AI-driven universal cardiac remote monitoring platform to provide high-value services to healthcare providers Cambridge, Mass., May 27, 2021 –...
